A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28
Teng Fang(Beijing University of Posts and Telecommunications), Mu Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Lugui Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Li(Guiyang Medical University), Gang An(RAM Laboratories (United States)), Zhentao Yu(Dalian Ocean University), Bin He(Guiyang Medical University), Hao Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoyu Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yonglong Zhao(Guiyang Medical University), Xiyue Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Shiyi Xie(Simon Fraser University), Lixin Gong(Chinese Academy of Medical Sciences & Peking Union Medical College), Lanting Liu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 3
Related Papers
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
Overview of lethal human coronaviruses
|Signal Transduction and Targeted Therapy|2020|312
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
|Acta Neuropathologica Communications|2017|306